no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla)
|
Pisciotta, Livia |
|
2015 |
9 |
6 |
p. 837-846 10 p. |
article |
2 |
Author Index to Volume 9
|
|
|
2015 |
9 |
6 |
p. e1-e3 nvt p. |
article |
3 |
Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients
|
Dayspring, Thomas D. |
|
2015 |
9 |
6 |
p. 807-816 10 p. |
article |
4 |
Body mass index correlates with atherogenic lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men
|
Guardiola, Montse |
|
2015 |
9 |
6 |
p. 824-831.e1 7487 p. |
article |
5 |
Circulating non–HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease
|
Zhu, Cheng-Gang |
|
2015 |
9 |
6 |
p. 794-800 7 p. |
article |
6 |
Comparison of cardiometabolic risk biomarkers from a national clinical laboratory with the US adult population
|
Wolin, Elliott |
|
2015 |
9 |
6 |
p. 817-823 7 p. |
article |
7 |
Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions
|
Homma, Koichiro |
|
2015 |
9 |
6 |
p. 751-757 7 p. |
article |
8 |
Editorial Board
|
|
|
2015 |
9 |
6 |
p. A1-A2 nvt p. |
article |
9 |
Effect of DHA-rich fish oil on PPARγ target genes related to lipid metabolism in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial
|
Mansoori, Anahita |
|
2015 |
9 |
6 |
p. 770-777 8 p. |
article |
10 |
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
|
Moriarty, Patrick M. |
|
2015 |
9 |
6 |
p. 758-769 12 p. |
article |
11 |
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study
|
Braamskamp, Marjet J.A.M. |
|
2015 |
9 |
6 |
p. 741-750 10 p. |
article |
12 |
Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk
|
Saavedra, Yascara G. Luna |
|
2015 |
9 |
6 |
p. 786-793.e1 7145 p. |
article |
13 |
From the Editor: Is a goal a target?
|
Brown, W. Virgil |
|
2015 |
9 |
6 |
p. 727-730 4 p. |
article |
14 |
JCL roundtable: Apolipoproteins as causative elements in vascular disease
|
Brown, W. Virgil |
|
2015 |
9 |
6 |
p. 733-740 8 p. |
article |
15 |
Keyword Index to Volume 9
|
|
|
2015 |
9 |
6 |
p. e4-e7 nvt p. |
article |
16 |
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
|
Langslet, Gisle |
|
2015 |
9 |
6 |
p. 778-785 8 p. |
article |
17 |
Marked lowering of high-density lipoprotein cholesterol levels due to high dose bexarotene therapy
|
Basani, Samata |
|
2015 |
9 |
6 |
p. 832-836 5 p. |
article |
18 |
News from the NLA
|
|
|
2015 |
9 |
6 |
p. 731-732 2 p. |
article |
19 |
Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol
|
Goliasch, Georg |
|
2015 |
9 |
6 |
p. 801-806.e1 7260 p. |
article |
20 |
Retraction notice to “Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia” J Clin Lipidol 9 (2015) 447
|
McCrindle, Brian W. |
|
2015 |
9 |
6 |
p. 847- 1 p. |
article |
21 |
Table of Contents
|
|
|
2015 |
9 |
6 |
p. A3-A5 nvt p. |
article |